News for Humanigen, Inc. (HGEN)

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company...

NEW YORK, 07 août 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui...

Appointment of John Hohneker, M.D. Resignation of Chidozie Ugwumba PHILADELPHIA, April 1, 2024 /PRNewswire/ -- Carisma Therapeutics Inc.  , a clinical-stage biopharmaceutical company focused on...

(Bloomberg) -- Soaring rents and cheap funding made blocks of US rental apartments seem like a “can’t miss” investment during the pandemic. Developers piled in to take advantage by constructing millions of the multifamily units, while investors snapped up older complexes to renovate them. Most Read from BloombergFAA Orders Temporary Grounding of Some 737 Max Jets After MishapAckman Plans to Check MIT’s Kornbluth, Staff for PlagiarismBoeing 737 Max Blowout Points to Pervasive FlawsA Boom, a Whoos

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Humanigen, Inc. Humanigen, Inc.'s securities were suspended on July 26, 2023, and have not

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Humanigen, Inc. Humanigen,...

Humanigen, Inc. dropped from S&P TMI Index...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.08%

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05. The S&P 500, also rose, gaining, 0.48% to 4,576.60.

Humanigen (HGEN) fell ~70% Tuesday after announcing its shares will be delisted from Nasdaq and the company is evaluating a potential bankruptcy. Read more here.

The top 10 stocks with the highest insider sentiment score have been highlighted in this article.

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the commercialization of space technologies and services.

/PRNewswire/ -- The newly published report titled "Global COVID-19 Therapeutics Market– By Trends, Industry Competition Analysis, Clinical Trial/Pipeline...

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest ...

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new ...

GuruFocus Article or News written by insider and the topic is about: